Comparator 2

DRUG6 trials

Sponsors

AbbVie, AJU Pharm Co., Ltd., National University of Singapore, GlaxoSmithKline

Conditions

DentalInfluenza, HumanPsoriasisType2 Diabetes Mellitus

Phase 1

A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults

Not yet recruitingNCT07034781

AJU Pharm Co., Ltd.Type2 Diabetes Mellitus

Start: 2025-08-31End: 2025-11-30Target: 50Updated: 2025-06-24

A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults: Fed State Study

Not yet recruitingNCT07044765

AJU Pharm Co., Ltd.Type2 Diabetes Mellitus

Start: 2025-08-31End: 2025-11-30Target: 32Updated: 2025-07-01

Phase 2

A Study to Assess the Immune Response and Safety of a Vaccine Against Influenza in Adults 18 Years of Age and Older

CompletedNCT07121192

GlaxoSmithKlineInfluenza, Human

Start: 2025-08-25End: 2026-05-11Updated: 2026-05-28

A Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and Above

CompletedNCT07204964

GlaxoSmithKlineInfluenza, Human

Start: 2025-10-07End: 2026-08-24Updated: 2026-09-18

Unknown Phase

Study to Assess Adverse Events When Subcutaneous Risankizumab Injection is Given to Adult Participants With Psoriasis in Real World Setting

WithdrawnNCT04799990

AbbViePsoriasis

Start: 2021-06-23End: 2022-03-10Updated: 2022-12-09

Financial Incentives to Encourage Uptake of Preventive Dental Care Services Among Adults

Active, not recruitingNCT07083453

National University of SingaporeDental

Start: 2023-12-01End: 2026-03-31Updated: 2025-07-24